694 related articles for article (PubMed ID: 28952435)
1. Virus-Host Interactions: New Insights and Advances in Drug Development Against Viral Pathogens.
Prasad M; Ranjan K; Brar B; Shah I; Lalmbe U; Manimegalai J; Vashisht B; Gaury M; Kumar P; Khurana SK; Prasad G; Rawat J; Yadav V; Kumar S; Rao R
Curr Drug Metab; 2017; 18(10):942-970. PubMed ID: 28952435
[TBL] [Abstract][Full Text] [Related]
2. Medicinal and Therapeutic Potential of Herbs and Plant Metabolites / Extracts Countering Viral Pathogens - Current Knowledge and Future Prospects.
Dhama K; Karthik K; Khandia R; Munjal A; Tiwari R; Rana R; Khurana SK; Sana Ullah ; Khan RU; Alagawany M; Farag MR; Dadar M; Joshi SK
Curr Drug Metab; 2018; 19(3):236-263. PubMed ID: 29380697
[TBL] [Abstract][Full Text] [Related]
3. New horizons for antiviral drug discovery from virus-host protein interaction networks.
de Chassey B; Meyniel-Schicklin L; Aublin-Gex A; André P; Lotteau V
Curr Opin Virol; 2012 Oct; 2(5):606-13. PubMed ID: 23025912
[TBL] [Abstract][Full Text] [Related]
4. New antiviral compounds.
Streissle G; Paessens A; Oediger H
Adv Virus Res; 1985; 30():83-138. PubMed ID: 2421553
[TBL] [Abstract][Full Text] [Related]
5. Influenza virus-host interactomes as a basis for antiviral drug development.
Watanabe T; Kawaoka Y
Curr Opin Virol; 2015 Oct; 14():71-8. PubMed ID: 26364134
[TBL] [Abstract][Full Text] [Related]
6. Perspectives on antiviral drug development.
Wainberg MA
Antiviral Res; 2009 Jan; 81(1):1-5. PubMed ID: 18948140
[TBL] [Abstract][Full Text] [Related]
7. Modeling Viral Infectious Diseases and Development of Antiviral Therapies Using Human Induced Pluripotent Stem Cell-Derived Systems.
Trevisan M; Sinigaglia A; Desole G; Berto A; Pacenti M; Palù G; Barzon L
Viruses; 2015 Jul; 7(7):3835-56. PubMed ID: 26184286
[TBL] [Abstract][Full Text] [Related]
8. A Hepatitis C virus-host interaction involved in viral replication: toward the identification of antiviral targets.
Suzuki T
Jpn J Infect Dis; 2010 Sep; 63(5):307-11. PubMed ID: 20858994
[TBL] [Abstract][Full Text] [Related]
9. Systematic approaches towards the development of host-directed antiviral therapeutics.
Prussia A; Thepchatri P; Snyder JP; Plemper RK
Int J Mol Sci; 2011; 12(6):4027-52. PubMed ID: 21747723
[TBL] [Abstract][Full Text] [Related]
10. Antivirals other than for HIV therapy.
Harrison CJ
Adv Pediatr; 2000; 47():335-94. PubMed ID: 10959449
[TBL] [Abstract][Full Text] [Related]
11. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
12. [Prospects and current data in antiviral chemotherapy].
Huraux JM; Ingrand D; Agut H; Devillechabrolle A
Rev Pneumol Clin; 1989; 45(3):99-105. PubMed ID: 2685967
[TBL] [Abstract][Full Text] [Related]
13. Human viral diseases: what is next for antiviral drug discovery?
De Clercq E
Curr Opin Virol; 2012 Oct; 2(5):572-9. PubMed ID: 22846888
[TBL] [Abstract][Full Text] [Related]
14. The future of antivirals: broad-spectrum inhibitors.
Debing Y; Neyts J; Delang L
Curr Opin Infect Dis; 2015 Dec; 28(6):596-602. PubMed ID: 26524332
[TBL] [Abstract][Full Text] [Related]
15. [Advances in antiviral chemotherapy].
Baba M
Uirusu; 2005 Jun; 55(1):69-75. PubMed ID: 16308532
[TBL] [Abstract][Full Text] [Related]
16. A dual controllability analysis of influenza virus-host protein-protein interaction networks for antiviral drug target discovery.
Ackerman EE; Alcorn JF; Hase T; Shoemaker JE
BMC Bioinformatics; 2019 Jun; 20(1):297. PubMed ID: 31159726
[TBL] [Abstract][Full Text] [Related]
17. Dengue Virus Evolution under a Host-Targeted Antiviral.
Plummer E; Buck MD; Sanchez M; Greenbaum JA; Turner J; Grewal R; Klose B; Sampath A; Warfield KL; Peters B; Ramstedt U; Shresta S
J Virol; 2015 May; 89(10):5592-601. PubMed ID: 25762732
[TBL] [Abstract][Full Text] [Related]
18. The C-Terminal Tail of TRIM56 Dictates Antiviral Restriction of Influenza A and B Viruses by Impeding Viral RNA Synthesis.
Liu B; Li NL; Shen Y; Bao X; Fabrizio T; Elbahesh H; Webby RJ; Li K
J Virol; 2016 May; 90(9):4369-4382. PubMed ID: 26889027
[TBL] [Abstract][Full Text] [Related]
19. Achievements and challenges in antiviral drug discovery.
Littler E; Oberg B
Antivir Chem Chemother; 2005; 16(3):155-68. PubMed ID: 16004079
[TBL] [Abstract][Full Text] [Related]
20. Drug Repurposing for Viral Infectious Diseases: How Far Are We?
Mercorelli B; Palù G; Loregian A
Trends Microbiol; 2018 Oct; 26(10):865-876. PubMed ID: 29759926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
